Scientific Program

Day I
26th August 2017
09:45 - 10.00 AM Introductions and Welcome B. M. Makkar  
10.00-11.15 AM SESSION 1   V. Mohan, R. Chawla
  Glucagon revisited Adi Mehta  
  Pathobiology of Diabetes Complications Melissa Ng  
  Insulin Therapy in 2020 Mario Skugor  
11.15 - 11.45 AM Debate - Weight Gain is An Over-Hyped Adverse Effect of Diabetes Treatments For- Adi Mehta
Against- M. Skugor
Krishna Kumar, Sanjay Agarwal
11.45 - 12.00 PM TEA BREAK
12:00 - 01.15 PM SESSION 2   Rohit Kapoor, J. K. Sharma
  Looking beyond Glycaemic Control – Addressing  Cardiac Protection Melissa Ng  
  Looking beyond Glycaemic Control – Addressing  Renal Protection M. Skugor  
  Diabetes Drugs for the Renal Compromised Patient C. Faiman  
01.15 - 02.15 PM LUNCH BREAK
02.15 - 02.45 PM Personalised Diabetes Care – Are we there yet? V. Mohan S. Banerjee, J. Ahmed
02.45 - 04.00 PM SESSION 3    
  Old Problems, New Solutions - Insulin Management through Innovation - Concentrated Insulins, Biosimilars Adi Mehta Jothydev, D. K. Hazra
  Closed loop pump technology M. Skugor  
  Prevention of Diabetes V. Mohan  
04.00 - 04.30 PM TEA BREAK
04.30 - 05.45 PM SESSION 4   S. R. Aravind, R. K. Marya
  Stress Hyperglycaemia Adi Mehta  
  Male hypogonadism C. Faiman  
  Diabetes in Young  - TBD  
05.45 - 06.15 PM DEBATE – Hypoglycaemia Is An Over-Hyped Complication of Sulfonylureas For - C. Faiman
Against - Adi Mehta
Dheeraj Kapoor, Manoj Chawla
06.15 - 07.00 PM Case Studies B. M. Makkar Cle Faculty, A. K. Das, A. K. Singh, R. Chawla
7.00 PM onwards Dinner and Fellowship
Day II
27th August 2017
09.00 - 10:15 AM SESSION 5   Arvind Gupta, Sunil Gupta
  Conventional Therapies for T2DM – MET+SU- Where do we stand? TBD  
  Newer Therapies – GLP1 RA, Gliptins, SGLT2s – Are they making a difference in achieving glycaemic goals Melissa Ng  
  Next Generation of Therapies for Type 2 Diabetes C. Faiman  
10:15 - 10.45 AM Alpha, Beta, Delta of Islet Function  and Coordination Adi Mehta S. R. Aravind, Banshi Saboo
10.45 - 11.15 AM TEA BREAK
11.15 - 12.30 PM SESSION 6   Shalini Jaggi, J. K. Sharma
  Managing HTN in Diabetes – Do newer agents(azilsartan, cilnidipine)  offer any advantage? S. Joshi  
  Do we need to test fasting blood samples for managing diabetes? B. M. Makkar  
  The New ADA Consensus Guidelines on Diabetic Peripheral Neuropathy - Will They Change Your Practice/Management? Mario Skugor  
12.30 - 01.00 PM Recent Advances - Snapshot ADA 2017 S. Joshi R. K. Marya, Vinod Mittal
01.00 - 02.00 PM LUNCH BREAK
02.00 - 03.30 PM SESSION 7   A. K. Singh, Rajeev Kovil
  Gliptin CVOTs – What did they tell us? Adi Mehta  
  GLP 1RA CVOTs - where do we stand? A. Mithal  
  CANVAS – Cana Proves the Point Mario Skugor  
  CVD Real Melissa Ng  
  DEVOTE Melissa Ng  
  Cardiovascular Outcomes Trials – Do these make sense...or dollars? C. Faiman  
03.30 - 04.30 PM Interaction with Expert Panel - Open House All Faculty  

26August 2017 – Workshops 1&2
11.45am-1.15pm - Clinical Decision Making based on RSSDI Clinical Practice Guidelines for Indians... Rajeev Chawla, Banshi Saboo
3.00-4.30pm - Technologies in Diabetes Management... Jothydev, Rajeev Kovil, Manoj Chawla

Attendance to workshops by prior registration, limited to 75 delegates on first come first serve basis.

27th August 2017 – Workshop 3&4
9.15-10.30am – Insulin Initiation, Intensification and Optimisation in Clinical Practice... AK Das, Dr Banshi Saboo
11.00am-12.30pm - Workshop on DEVOTE Trial - Dr. AK Singh, Dr Rajeev Chawla

Attendance to workshops by prior registration, limited to 75 delegates on first come first serve basis.

Please Contact

Dr. B. M. Makkar
Diabetes and Obesity Centre
A – 5B/122, Paschim Vihar, New Delhi – 110 063
Tel: +91-11-2526 7671 / 2528 0150
Fax: +91-11-4568 3367
Mobile: +91-98-110-77419

Connect with us

Official Conference Manager

CIMGlobal India Pvt. Ltd.
Suite No. 309-311, DLF City Court,
MG Road Gurgaon 122 004, Haryana, India
Pratibha Verma
Mob: +91 73513 01122

© CCACCD.COM All rights reserved.